Mark J Alles's Net Worth
Mark J Alles's net worth is estimated to be at least $15,096,630.87 as of 12/22/2024. CoreStreet's estimation of Mark J Alles's net worth is based on their sale of stock and current holding of stock.
Mark J Alles is Director at Biomarin Pharmaceutical Inc. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,625 units of BMRN stock on 10/31/2022. Their biggest sale was on 02/06/2015 when they sold 117,099 units of Bristol-Myers Squibb Company stock for $14,131,507.32. They typically trade 1 times per year.
Total value of insider buys:
- $965,123.55
Total value of insider sells:
- $14,131,507.32
Most recent insider trade:
- Oct. 31, 2022
Mark J Alles's Insider Trading History
| Biomarin Pharmaceutical Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 31, 2022 | Director | 3,625 | $86.75 | Buy | $314,468.75 |
| Turning Point Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 21, 2021 | Director | 2,000 | $81.34 | Buy | $162,680.00 |
| Syros Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 13, 2020 | Director | 10,000 | $8.86 | Buy | $88,600.00 |
| Bristol-Myers Squibb Company | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 9, 2018 | CEO | 1,208 | $82.60 | Buy | $99,780.80 |
Feb. 8, 2018 | Insider | 3,260 | $91.90 | Buy | $299,594.00 |
Feb. 6, 2015 | Insider | 117,099 | $120.68 | Sell | $14,131,507.32 |